AGIO logo

Agios Pharmaceuticals (AGIO) Company Overview

Profile

Full Name:

Agios Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 24, 2013

Indexes:

Not included

Website:

http://www.agios.com

Description:

Agios Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on the development and commercialization of drugs in the field of cellular metabolism for patients with hematologic malignancies, oncology tumors, and rare genetic diseases. The company was registered in August 2007. The executive office is located in Cambridge, Massachusetts. The scientific approach of Agios Pharmaceuticals, Inc. is focused on using its proprietary technology to identify key metabolic enzymes in cancer or other diseased cells in the laboratory, and then using these key enzymes for screening and identifying candidate products targeting cellular metabolism and related areas of biology. The company's efforts are also focused on metabolic immuno-oncology.

Key Details

Price

$34.29

Market Cap

$1.96 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$36.50 M(+36.07% YoY)

Annual EPS

$11.64(+283.89% YoY)

PE Ratio

3.02

Annual ROE

57.29%

Annual Debt To Equity

0.00

Beta

1.56

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 18, 24 Cantor Fitzgerald
Overweight
Dec 10, 24 RBC Capital
Outperform
Dec 9, 24 Scotiabank
Sector Outperform
Nov 1, 24 Scotiabank
Sector Outperform
Oct 16, 24 Scotiabank
Sector Outperform
Sep 27, 24 Leerink Partners
Market Perform
Sep 20, 24 Cantor Fitzgerald
Overweight
Sep 19, 24 RBC Capital
Outperform
Aug 2, 24 RBC Capital
Outperform
Jun 17, 24 Cantor Fitzgerald
Overweight

Screeners with AGIO included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks
Earnings this week

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$34.29
AGIO price is $34.29

Price All-time High

$135.01
AGIO price is currently -74.60% below its historical high of $135.01

Price Analysts Target

$54.00
AGIO price is currently -36.50% lower than the consensus analysts' forecast

Price Most Recent Change

+3.6%
AGIO price was up +3.6% on Feb 14, 2025

Price YTD Change

+5.31%
AGIO price is up +5.31% since January 1st

Price 3-Year Change

+13.47%
AGIO price is up +13.47% over the past 3 years

Market cap

Market Cap

$1.96 B
AGIO market capitalization is $1.96 billion

Market Cap 3-Year Change

+19.65%
AGIO market capitalization is up +19.65% over the past 3 years

Market Cap All-time High

$5.73 B
AGIO market capitalization is currently -65.74% below its historical high of $5.73 billion

Market Cap Sector Rank

80.99%
AGIO market capitalization is higher than 80.99% of companies in Healthcare sector

Technical

Beta

1.56
AGIO beta is 1.56

200-day SMA

$42.87
AGIO price is currently -20.01% below its 200-day simple moving average

14-day RSI

42.19
AGIO 14-day relative strength index is 42.19

30-day Relative Volume

1.03
AGIO 30-day relative volume is 1.03

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$36.50 M
AGIO annual revenue is $36.50 million

Annual Revenue Analysts Estimate

$54.50 M
AGIO annual revenue is currently -33.03% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+36.07%
AGIO annual revenue is up +36.07% year-on-year

Annual Revenue Sector Rank

44.31%
AGIO annual revenue is higher than 44.31% of companies in Healthcare sector

Profit

Annual Gross Profit

$32.33 M
AGIO annual gross profit is $32.33 million

Annual Gross Margin

88.59%
AGIO annual gross profit margin is 88.59%

Annual Operating Profit

-$425.74 M
AGIO annual operating income is -$425.74 million

Annual Operating Margin

-1166.47%
AGIO annual operating profit margin is -1166.47%

Annual Net Income

$673.73 M
AGIO annual net profit is $673.73 million

Annual Net Margin

-
AGIO annual net profit margin value is unknown

EPS

Annual EPS

$11.64
AGIO annual earnings per share is $11.64

Annual EPS Analysts Estimate

-$7.19
AGIO annual earnings per share is currently -261.89% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+283.89%
AGIO annual earnings per share is up +283.89% year-on-year

Annual EPS Sector Rank

98.7%
AGIO annual earnings per share is higher than 98.7% of companies in Healthcare sector

ROA & ROE

Annual ROA

51.82%
AGIO annual return on assets is 51.82%

Annual ROE

57.29%
AGIO annual return on equity is 57.29%

EBIT & EBITDA

Annual EBIT

-$425.74 M
AGIO annual earnings before interest & taxes is -$425.74 million

Annual EBITDA

-$420.08 M
AGIO annual EBITDA is -$420.08 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

3.02
AGIO price to earnings ratio is 3.02

PE Ratio Sector Rank

3.54%
AGIO price to earnings ratio is higher than 3.54% of companies in Healthcare sector

PB Ratio

PB Ratio

1.27
AGIO price to book ratio is 1.27

PB Ratio Sector Rank

46.55%
AGIO price to book ratio is higher than 46.55% of companies in Healthcare sector

PS Ratio

PS Ratio

53.83
AGIO price to sales ratio is 53.83

PS Ratio Sector Rank

91.62%
AGIO price to sales ratio is higher than 91.62% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.95 B
AGIO enterprise value is $1.95 billion

Enterprise Value Sector Rank

81.01%
AGIO enterprise value is higher than 81.01% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.63
AGIO EV/EBITDA is -4.63

EV/EBITDA Sector Rank

25.11%
AGIO EV/EBITDA is higher than 25.11% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

11.90
AGIO annual current ratio is 11.90

Annual Quick Ratio

11.56
AGIO annual quick ratio is 11.56

Leverage

Annual Debt To Equity

0.00
AGIO annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
AGIO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
AGIO piotroski f-score is 3

Altman Z-Score

9.33
AGIO altman z-score is 9.33

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.66 B
AGIO annual total assets is $1.66 billion

Annual Non Current Assets

$697.60 M
AGIO annual long term assets is $697.60 million

Annual Current Assets

$965.60 M
AGIO annual total current assets is $965.60 million

Annual Cash & Cash Equivalents

$76.25 M
AGIO annual cash & cash equivalents is $76.25 million

Equity

Annual Book Value

$1.54 B
AGIO annual book value is $1.54 billion

Annual Working Capital

$884.44 M
AGIO annual working capital is $884.44 million

Liabilities

Annual Total Liabilities

$122.24 M
AGIO annual total liabilities is $122.24 million

Annual Total Long Term Liabilities

$41.09 M
AGIO annual total long term liabilities is $41.09 million

Annual Current Liabilities

$81.16 M
AGIO annual total current liabilities is $81.16 million

Annual Accounts Payable

$16.64 M
AGIO annual accounts payable is $16.64 million

Debt

Annual Total Debt

$56.99 M
AGIO annual total debt is $56.99 million

Annual Total Debt 1-Year Change

-20.85%
AGIO annual total debt is down -20.85% year-on-year

Annual Long Term Debt

$40.21 M
AGIO annual long term debt is $40.21 million

Annual Short Term Debt

$16.78 M
AGIO annual short term debt is $16.78 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$462.24 M
AGIO annual total expenses is $462.24 million

Annual Operating Expenses

$458.07 M
AGIO annual total operating expenses is $458.07 million

Annual Cost Of Goods Sold

$4.17 M
AGIO annual cost of goods sold is $4.17 million

Annual SGA

$156.78 M
AGIO annual SGA is $156.78 million

Annual D&A

$5.65 M
AGIO annual depreciation & amortization is $5.65 million

Annual Interest Expense

-
AGIO annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$389.84 M
AGIO annual cash flow from operations is -$389.84 million

Annual CFO 1-Year Change

-31.68%
AGIO annual cash flow from operations is down -31.68% year-on-year

Annual CFI

$363.44 M
AGIO annual cash flow from investing activities is $363.44 million

Annual CFI 1-Year Change

+51.7%
AGIO annual cash flow from investing activities is up +51.7% year-on-year

Annual CFF

$14.44 M
AGIO annual cash flow from financing activities is $14.44 million

Annual CFF 1-Year Change

+165.82%
AGIO annual cash flow from financing activities is up +165.82% year-on-year

Free CashFlow

Annual FCF

-$391.53 M
AGIO annual free cash flow is -$391.53 million

Annual FCF 1-Year Change

-24.47%
AGIO annual free cash flow is down -24.47% year-on-year

CAPEX

Annual CAPEX

$1.69 M
AGIO annual capital expenditures is $1.69 million

Annual CAPEX 1-Year Change

-90.89%
AGIO annual capital expenditures is down -90.89% year-on-year

Institutional Ownership

Similar stocks

GDRX logo
GoodRx Holdings (GDRX)
UFPT logo
UFP Technologies (UFPT)
ATRC logo
AtriCure (ATRC)
CGON logo
CG Oncology (CGON)
GRAL logo
GRAIL (GRAL)
CNMD logo
CONMED (CNMD)
TARS logo
Tarsus Pharmaceuticals (TARS)
JANX logo
Janux Therapeutics (JANX)
PGNY logo
Progyny (PGNY)

FAQ

  • What is the ticker symbol for Agios Pharmaceuticals?
  • Does Agios Pharmaceuticals pay dividends?
  • What sector is Agios Pharmaceuticals in?
  • What industry is Agios Pharmaceuticals in?
  • What country is Agios Pharmaceuticals based in?
  • When did Agios Pharmaceuticals go public?
  • Is Agios Pharmaceuticals in the S&P 500?
  • Is Agios Pharmaceuticals in the NASDAQ 100?
  • Is Agios Pharmaceuticals in the Dow Jones?
  • When was Agios Pharmaceuticals's last earnings report?
  • When does Agios Pharmaceuticals report earnings?
  • Should I buy Agios Pharmaceuticals stock now?

What is the ticker symbol for Agios Pharmaceuticals?

The ticker symbol for Agios Pharmaceuticals is NASDAQ:AGIO

Does Agios Pharmaceuticals pay dividends?

No, Agios Pharmaceuticals does not pay dividends

What sector is Agios Pharmaceuticals in?

Agios Pharmaceuticals is in the Healthcare sector

What industry is Agios Pharmaceuticals in?

Agios Pharmaceuticals is in the Biotechnology industry

What country is Agios Pharmaceuticals based in?

Agios Pharmaceuticals is headquartered in United States

When did Agios Pharmaceuticals go public?

Agios Pharmaceuticals's initial public offering (IPO) was on July 24, 2013

Is Agios Pharmaceuticals in the S&P 500?

No, Agios Pharmaceuticals is not included in the S&P 500 index

Is Agios Pharmaceuticals in the NASDAQ 100?

No, Agios Pharmaceuticals is not included in the NASDAQ 100 index

Is Agios Pharmaceuticals in the Dow Jones?

No, Agios Pharmaceuticals is not included in the Dow Jones index

When was Agios Pharmaceuticals's last earnings report?

Agios Pharmaceuticals's most recent earnings report was on Feb 13, 2025

When does Agios Pharmaceuticals report earnings?

The next expected earnings date for Agios Pharmaceuticals is May 2, 2025

Should I buy Agios Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions